Alkeus Pharmaceuticals Appoints Carlos Quezada-Ruiz as Chief Medical Officer

Alkeus Pharmaceuticals; Carlos Quezada-Ruiz; Chief Medical Officer; Stargardt disease; gildeuretinol; retinal diseases; ophthalmology; clinical research; biopharmaceutical leadership

Whitehawk Therapeutics Appoints Margaret Dugan as Chief Medical Officer

Whitehawk Therapeutics; Margaret Dugan; Chief Medical Officer; CMO; oncology; ADC; drug development; clinical trials; Novartis; Dracen Pharmaceuticals; Schrödinger

Syndeio Biosciences Appoints Aaron Koenig, M.D., as Chief Medical Officer (CMO)

Syndeio Biosciences; Aaron Koenig; Chief Medical Officer; CNS disorders; synaptic health; neuroscience drug development; zelquistinel; Alzheimer’s disease; neuropsychiatric; clinical trials